Cargando…
An open label follow-up study on amisulpride in the add-on treatment of bipolar I patients
BACKGROUND: Atypical antipsychotics are widely used in the treatment of bipolar disorders. Amisulpride is an atypical antipsychotic that has been proven to be effective in treatment of schizophrenia, major depressive disorder and, more recently, acute mania. At the moment, however, no study has asse...
Autores principales: | Carta, Mauro Giovanni, Zairo, Fausta, Mellino, Gisa, Hardoy, Maria Carolina, Vieta, Eduard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560121/ https://www.ncbi.nlm.nih.gov/pubmed/16930471 http://dx.doi.org/10.1186/1745-0179-2-19 |
Ejemplares similares
-
Add-on quetiapine in the treatment of major depressive disorder in elderly patients with cerebrovascular damage
por: Carta, Mauro Giovanni, et al.
Publicado: (2007) -
Quetiapine as add-on treatment for bipolar I disorder: efficacy in preventing relapse of depressive episodes
por: Hardoy, Maria Carolina, et al.
Publicado: (2007) -
Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder
por: Hardoy, Maria Carolina, et al.
Publicado: (2010) -
Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial
por: Thomas, Pierre, et al.
Publicado: (2008) -
Benefits of Exercise with Mini Tennis in Intellectual Disabilities: Effects on Body Image and Psychopathology
por: Hardoy, Maria Carolina, et al.
Publicado: (2011)